Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants
Crossref DOI link: https://doi.org/10.1007/s40121-017-0178-6
Published Online: 2017-11-17
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pavilack, Melissa
Clifford, Robert A.
Gonzales, Tara
Kong, Amanda M.
Wade, Sally
McLaurin, Kimmie K.
Funding for this research was provided by:
AstraZeneca
